These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29435122)

  • 21. Mutational context and diverse clonal development in early and late bladder cancer.
    Nordentoft I; Lamy P; Birkenkamp-Demtröder K; Shumansky K; Vang S; Hornshøj H; Juul M; Villesen P; Hedegaard J; Roth A; Thorsen K; Høyer S; Borre M; Reinert T; Fristrup N; Dyrskjøt L; Shah S; Pedersen JS; Ørntoft TF
    Cell Rep; 2014 Jun; 7(5):1649-1663. PubMed ID: 24835989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
    Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC Mutagenesis and Copy-Number Alterations Are Drivers of Proteogenomic Tumor Evolution and Heterogeneity in Metastatic Thoracic Tumors.
    Roper N; Gao S; Maity TK; Banday AR; Zhang X; Venugopalan A; Cultraro CM; Patidar R; Sindiri S; Brown AL; Goncearenco A; Panchenko AR; Biswas R; Thomas A; Rajan A; Carter CA; Kleiner DE; Hewitt SM; Khan J; Prokunina-Olsson L; Guha U
    Cell Rep; 2019 Mar; 26(10):2651-2666.e6. PubMed ID: 30840888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOBEC shapes tumor evolution and age at onset of lung cancer in smokers.
    Zhang T; Sang J; Hoang PH; Zhao W; Rosenbaum J; Johnson KE; Klimczak LJ; McElderry J; Klein A; Wirth C; Bergstrom EN; Díaz-Gay M; Vangara R; Colon-Matos F; Hutchinson A; Lawrence SM; Cole N; Zhu B; Przytycka TM; Shi J; Caporaso NE; Homer R; Pesatori AC; Consonni D; Imielinski M; Chanock SJ; Wedge DC; Gordenin DA; Alexandrov LB; Harris RS; Landi MT
    bioRxiv; 2024 Apr; ():. PubMed ID: 38617360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide Weight Matrices Reveal Ubiquitous Mutational Footprints of AID/APOBEC Deaminases in Human Cancer Genomes.
    Rogozin IB; Roche-Lima A; Lada AG; Belinky F; Sidorenko IA; Glazko GV; Babenko VN; Cooper DN; Pavlov YI
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30759888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different members of the APOBEC3 family of DNA mutators have opposing associations with the landscape of breast cancer.
    Asaoka M; Patnaik SK; Ishikawa T; Takabe K
    Am J Cancer Res; 2021; 11(10):5111-5125. PubMed ID: 34765315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOBEC-Induced Cancer Mutations Are Uniquely Enriched in Early-Replicating, Gene-Dense, and Active Chromatin Regions.
    Kazanov MD; Roberts SA; Polak P; Stamatoyannopoulos J; Klimczak LJ; Gordenin DA; Sunyaev SR
    Cell Rep; 2015 Nov; 13(6):1103-1109. PubMed ID: 26527001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients.
    Smal MP; Rolevich AI; Polyakov SL; Krasny SA; Goncharova RI
    Exp Oncol; 2014 Dec; 36(4):246-51. PubMed ID: 25537218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOBEC Mutagenesis in Cancer Development and Susceptibility.
    Dananberg A; Striepen J; Rozowsky JS; Petljak M
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KMT2C-deficient tumors have elevated APOBEC mutagenesis and genomic instability in multiple cancers.
    Hu X; Biswas A; De S
    NAR Cancer; 2022 Sep; 4(3):zcac023. PubMed ID: 35898555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Hedegaard J; Lamy P; Nordentoft I; Algaba F; Høyer S; Ulhøi BP; Vang S; Reinert T; Hermann GG; Mogensen K; Thomsen MBH; Nielsen MM; Marquez M; Segersten U; Aine M; Höglund M; Birkenkamp-Demtröder K; Fristrup N; Borre M; Hartmann A; Stöhr R; Wach S; Keck B; Seitz AK; Nawroth R; Maurer T; Tulic C; Simic T; Junker K; Horstmann M; Harving N; Petersen AC; Calle ML; Steyerberg EW; Beukers W; van Kessel KEM; Jensen JB; Pedersen JS; Malmström PU; Malats N; Real FX; Zwarthoff EC; Ørntoft TF; Dyrskjøt L
    Cancer Cell; 2016 Jul; 30(1):27-42. PubMed ID: 27321955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of activating fibroblast growth factor receptor 3 mutations in the development of bladder tumors.
    Zieger K; Dyrskjøt L; Wiuf C; Jensen JL; Andersen CL; Jensen KM; Ørntoft TF
    Clin Cancer Res; 2005 Nov; 11(21):7709-19. PubMed ID: 16278391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PrimPol prevents APOBEC/AID family mediated DNA mutagenesis.
    Pilzecker B; Buoninfante OA; Pritchard C; Blomberg OS; Huijbers IJ; van den Berk PC; Jacobs H
    Nucleic Acids Res; 2016 Jun; 44(10):4734-44. PubMed ID: 26926109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOBEC3A and APOBEC3B Preferentially Deaminate the Lagging Strand Template during DNA Replication.
    Hoopes JI; Cortez LM; Mertz TM; Malc EP; Mieczkowski PA; Roberts SA
    Cell Rep; 2016 Feb; 14(6):1273-1282. PubMed ID: 26832400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AID/APOBEC deaminases and cancer.
    Rebhandl S; Huemer M; Greil R; Geisberger R
    Oncoscience; 2015; 2(4):320-33. PubMed ID: 26097867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.
    Venkatesan S; Rosenthal R; Kanu N; McGranahan N; Bartek J; Quezada SA; Hare J; Harris RS; Swanton C
    Ann Oncol; 2018 Mar; 29(3):563-572. PubMed ID: 29324969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in TP53, but not FGFR3, in urothelial cell carcinoma of the bladder are influenced by smoking: contribution of exogenous versus endogenous carcinogens.
    Wallerand H; Bakkar AA; de Medina SG; Pairon JC; Yang YC; Vordos D; Bittard H; Fauconnet S; Kouyoumdjian JC; Jaurand MC; Zhang ZF; Radvanyi F; Thiery JP; Chopin DK
    Carcinogenesis; 2005 Jan; 26(1):177-84. PubMed ID: 15347601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDKN1A/p21
    Arnoff TE; El-Deiry WS
    Am J Cancer Res; 2021; 11(11):5452-5471. PubMed ID: 34873472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.